Dr. Michael Yeadon, Former Pfizer VP On the Dangers Of mRNA Vaccines & the COVID Illusion
4 K Views
58
3 years ago
⁣Joining us today is Pfizer's former Vice President and Chief Scientist for Allergy and Respiratory, Michael Yeadon, here to discuss his expert opinion on the topics of COVID-19, mRNA vaccine technology, as well as suppression and outright censorship of medical and scientific experts. 

All Video Source Links Can Be Found Here At The Last American Vagabond: https://www.thelastamericanvagabond.com/michael-yeadon-interview-former-pfizer-vp-speaks-out-on-dangers-of-mrna-vaccines-covid-illusion
Want to send a check to support TLAV, or just words of encouragement?Use our new P.O. box:Ryan Cristian1113 Murfreesboro Rd. Ste 106-146Franklin, Tn 37064

Get a TLAV "Question Everything" T-Shirt or Sticker at: https://truthclothing.io/collections/tlavSupport The Last American Vagabond by Subscribing here:http://www.feedblitz.com/f/?Sub=906867The Last American Vagabond Links: Minds: https://www.minds.com/TLAVagabond YouTube: https://www.youtube.com/channel/UCdLXk-XLylNh0QxgXAceHmgBitchute: https://www.bitchute.com/channel/24yVcta8zEjY/DLive: https://dlive.tv/TLAVagabond LBRY/Odysee: https://odysee.com/@TLAVagabond:5 Rumble: https://rumble.com/user/TheLastAmericanVagabondRokfin: https://www.rokfin.com/TLAVagabondhttps://brandnewtube.com/@TLAVagabond Brighteon: https://www.real.video/channel/tlavagabond Facebook: https://www.facebook.com/TheLastAmericanVagabond/Twitter: https://twitter.com/YoureAllDuncesParler: https://parler.com/profile/TLAVagabond/posts


"Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use.”


Source: ⁣https://www.bitchute.com/video/qs9X8Blr4Ucv/
Authentication required

You must log in to post a comment.

Log in